Silicon Valley at the Crossroads: How OpenAIβs IPO Push, the Apple Lawsuit, Chinese Open-Weight Models, and Deep-Tech Capital Are Redrawing the Global AI Order β Foreign Affairs Forum
β’ OpenAI researcher Miles Wang is departing the company to launch a new AI startup specifically focused on accelerating drug discovery. β’ Wang is currently in negotiations to raise approximately $200 million in funding, with a target valuation of $2 billion. β’ Venture capital firm Lightspeed is reportedly in discussions to lead the funding round for the new venture.
faf.ae